Copyright
©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Oct 27, 2018; 10(10): 772-779
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.772
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.772
Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature
Yi-Lan Lin, Department of Radiation Oncology, Rinecker Proton Therapy Center, Munich 81371, Germany
Author contributions: Lin YL performed all research and interpretive functions for this case report.
Supported by Rinecker Proton Therapy Center (RPTC), Munich, Germany .
Informed consent statement: After contacting the patient about the planned publication of his case, he provided written authorization.
Conflict-of-interest statement: The author states there are no potential conflicts of interest relevant to this publication.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Yi-Lan Lin, MD, Chief Doctor, Department of Radiation Oncology, Rinecker Proton Therapy Center, Schaeftlarnstr 133, Munich 81371, Germany. yi-lan.lin@rptc-1.de
Telephone: +49-89-724670 Fax: +49-89-72467352
Received: April 5, 2018
Peer-review started: April 6, 2018
First decision: May 16, 2018
Revised: June 14, 2018
Accepted: June 27, 2018
Article in press: June 28, 2018
Published online: October 27, 2018
Peer-review started: April 6, 2018
First decision: May 16, 2018
Revised: June 14, 2018
Accepted: June 27, 2018
Article in press: June 28, 2018
Published online: October 27, 2018
Core Tip
Core tip: Hepatocellular carcinoma (HCC) is one of the most common cancers in Asia. Patients with unresectable tumor disease require more options for in-principle curative therapies. We report here a patient with a large unresectable HCC due to vascular invasion and satellite metastases, who showed remarkable tumor shrinkage after completing proton beam therapy 4 years ago and who is still free of tumor recurrence to date.